Clinical Trials
5 trialsNCT02721732 2026-01-29
Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT03333616 2026-01-21
Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors
Dana-Farber Cancer Institute
Phase 2 Active not recruiting
NCT04926181 2025-05-15
Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer
University of California, San Francisco
Phase 2 Terminated
NCT05621837 2025-05-02
Serpentine
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Recruiting
NCT00469066 2016-02-24
Cone Beam CT Scanning in Lung and Bladder Cancer.
AHS Cancer Control Alberta
Completed